Evaluation of the Efficacy of Electroacupuncture in the Treatment of Chronic Atrophic Gastritis

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions
Chronic Atrophic Gastritis
Interventions
OTHER

5 Hz electroacupuncture combined tipronone capsules

Intervention Description: The intervention in this study involves the use of electroacupuncture (EA), a combination of traditional acupuncture and electrical stimulation. Acupoints Selection: Electroacupuncture will be performed at specific acupoints associated with the stomach and digestive system. The local acupoints chosen are Liangmen (ST21) and Tianshu (ST25), while the distal acupoints are Zusanli (ST36) and Xiajuxu (ST39). This selection is based on Traditional Chinese Medicine (TCM) principles for treating functional dyspepsia. Frequency: 5 Hz Patients will also be administered SviShu (tipronone capsules) (Wei Cai Pharmaceutical Co., Ltd., National Drug Approval Number H20093656, dosage: 50 mg) orally, one capsule at a time, three times daily, after meals.

DRUG

Simple tipronone capsules group(The basic treatment group)

Patients in the Simple tipronone capsules group(basic treatment group) will receive only conventional basic drug therapy. They will be given Svi-Shu (tipronone capsules) (Eisai Pharmaceutical Co., Ltd., national drug approval number H20093656, specification: 50 mg) orally, one capsule at a time, three times a day, after meals.

Trial Locations (3)

310007

Hangzhou TCM Hospital of Zhejiang Chinese Medical University (Hangzhou Hospital of Traditional Chinese Medicine), Hangzhou

310053

Hangzhou First People's Hospital, Hangzhou

The Third Affiliated Hospital of Zhejiang Chinese Medicinal University, Hangzhou

All Listed Sponsors
collaborator

Zhejiang Provincial Department of Science and Technology

UNKNOWN

lead

Yi Liang

OTHER

NCT07152860 - Evaluation of the Efficacy of Electroacupuncture in the Treatment of Chronic Atrophic Gastritis | Biotech Hunter | Biotech Hunter